Primary Site >> Pancreatic Cancer
Gene >> MUC13
| 1. | |||||||||||
| Journal: | Mol Cancer Ther. 2012 Jan;11(1):24-33. | ||||||||||
| Title: | MUC13 mucin augments pancreatic tumorigenesis. | ||||||||||
| Author: | Chauhan, Subhash C|Ebeling, Mara C|Maher, Diane M|Koch, Michael D|Watanabe, Akira|Aburatani, Hiroyuki|Lio, Yuhlong|Jaggi, Meena | ||||||||||
| PMID: | 22027689 | ||||||||||
| 2. | |||||||||||
| Journal: | Oncotarget. 2014 Sep 15;5(17):7599-609. | ||||||||||
| Title: | MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer. | ||||||||||
| Author: | Khan, Sheema|Ebeling, Mara C|Zaman, Mohd S|Sikander, Mohammed|Yallapu, Murali M|Chauhan, Neeraj|Yacoubian, Ashley M|Behrman, Stephen W|Zafar, Nadeem|Kumar, Deepak|Thompson, Paul A|Jaggi, Meena|Chauhan, Subhash C | ||||||||||
| PMID: | 25277192 | ||||||||||
| 3. | |||||||||||
| Journal: | Int J Oncol. 2015 Apr;46(4):1781-7. | ||||||||||
| Title: | A newly developed anti-Mucin 13 monoclonal antibody targets pancreatic ductal adenocarcinoma cells. | ||||||||||
| Author: | Nishii, Yukari|Yamaguchi, Miki|Kimura, Yasutoshi|Hasegawa, Tadashi|Aburatani, Hiroyuki|Uchida, Hiroaki|Hirata, Koichi|Sakuma, Yuji | ||||||||||
| PMID: | 25672256 | ||||||||||
| 4. | |||||||||||
| Journal: | J Gastrointest Surg. 2017 Jan;21(1):94-105. | ||||||||||
| Title: | Restitution of Tumor Suppressor MicroRNA-145 Using Magnetic Nanoformulation for Pancreatic Cancer Therapy. | ||||||||||
| Author: | Setua, Saini|Khan, Sheema|Yallapu, Murali M|Behrman, Stephen W|Sikander, Mohammed|Khan, Shabia Shabir|Jaggi, Meena|Chauhan, Subhash C | ||||||||||
| PMID: | 27507554 | ||||||||||
| 5. | |||||||||||
| Journal: | J Nat Sci. 2017 Mar;3(3). | ||||||||||
| Title: | miR-145: Revival of a Dragon in Pancreatic Cancer. | ||||||||||
| Author: | Setua, Saini|Khan, Sheema|Doxtater, Kyle|Yallapu, Murali M|Jaggi, Meena|Chauhan, Subhash C | ||||||||||
| PMID: | 28616589 | ||||||||||
| 6. | |||||||||||
| Journal: | HPB (Oxford). 2018 Jun;20(6):563-572. | ||||||||||
| Title: | Clinical significance of MUC13 in pancreatic ductal adenocarcinoma. | ||||||||||
| Author: | Khan, Sheema|Zafar, Nadeem|Khan, Shabia S|Setua, Saini|Behrman, Stephen W|Stiles, Zachary E|Yallapu, Murali M|Sahay, Peeyush|Ghimire, Hemendra|Ise, Tomoko|Nagata, Satoshi|Wang, Lei|Wan, Jim Y|Pradhan, Prabhakar|Jaggi, Meena|Chauhan, Subhash C | ||||||||||
| PMID: | 29352660 | ||||||||||
| 7. | |||||||||||
| Journal: | Oncogenesis. 2018 Feb 22;7(2):19. | ||||||||||
| Title: | MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer. | ||||||||||
| Author: | Kumari, Sonam|Khan, Sheema|Gupta, Subash C|Kashyap, Vivek K|Yallapu, Murali M|Chauhan, Subhash C|Jaggi, Meena | ||||||||||
| PMID: | 29467405 | ||||||||||
| 8. | |||||||||||
| Journal: | Pancreatology. 2018 Jun;18(4):407-412. | ||||||||||
| Title: | Clinicopathological and prognostic significance of MUC13 and AGR2 expression in intraductal papillary mucinous neoplasms of the pancreas. | ||||||||||
| Author: | Mito, Kumiko|Saito, Michihiro|Morita, Kohei|Maetani, Iruru|Sata, Naohiro|Mieno, Makiko|Fukushima, Noriyoshi | ||||||||||
| PMID: | 29650332 | ||||||||||